Synergistic action of the anticholinergic r,r-glycopyrrolate with glucocorticoids and PDE4-inhibitors

A. Pahl, J. Maus, P. Cnota, U. Petzold, I. Szelenyi (Erlangen, Bad Homburg, Germany)

Source: Annual Congress 2005 - New perspectives in asthma treatment
Session: New perspectives in asthma treatment
Session type: Poster Discussion
Number: 1404
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Pahl, J. Maus, P. Cnota, U. Petzold, I. Szelenyi (Erlangen, Bad Homburg, Germany). Synergistic action of the anticholinergic r,r-glycopyrrolate with glucocorticoids and PDE4-inhibitors. Eur Respir J 2005; 26: Suppl. 49, 1404

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Do long-acting β2-adrenoceptor agonists enhance the anti-inflammatory effect of glucocorticoids in asthma?
Source: Eur Respir J 2001; 17: 1059-1061
Year: 2001


TNFα-induced glucocorticoid resistance: Effect of steroidal and non-steroidal GR agonists, formoterol and inhibition of inflammatory signalling
Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung
Year: 2012

Antioxidant activity of anticholinergic bronchodilatators
Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II
Year: 2008


Anti-inflammatory properties of synthetic and endogenous Rev-Erb-alpha agonists.
Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms
Year: 2020


Protective effect of inhaled anticholinergic drugs in the methacholine test
Source: Eur Respir J 2007; 30: Suppl. 51, 619s
Year: 2007

LATE-BREAKING ABSTRACT: GW870086: A potent anti-inflammatory glucocorticoid with a novel pharmacological profile
Source: Annual Congress 2013 –Hot topics on airway diseases: new horizons in treatment
Year: 2013


Anti-inflammatory, antioxidant and immunomodulatory effects of curcumin in sensitized rat
Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology
Year: 2017


Novel anti-inflammatory agents
Source: Annual Congress 2009 - Emerging trends in the therapy of COPD
Year: 2009


A combination of thyme and ivy exerts potent anti-inflammatory and mucus-normalizing activity in vivo and inhibits 5-LO and PDE4
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014

Mechanisms of systemic side effects of inhaled steroids
Source: Eur Respir J 2004; 24: Suppl. 48, 347s
Year: 2004

Prolonged activity where it matters - the reversible esterfication of budesonide improves its topical anti-inflammatory efficacy and selectivity in the airways
Source: Eur Respir J 2001; 18: Suppl. 33, 21s
Year: 2001

Novel inhibitory effect on 5-lipoxygenase activity by montelukast. Evidence for a noncompetitive mode of action
Source: Eur Respir J 2004; 24: Suppl. 48, 96s
Year: 2004

First line anti-inflammatory treatment for asthma: inhaled steroid or leukotriene antagonist?
Source: Eur Respir J 2002; 20: Suppl. 38, 93s
Year: 2002

The combination of budesonide and formoterol exerts more rapid and enhanced anti-inflammatory effects than either drug alone in rat lungs in vivo
Source: Eur Respir J 2004; 24: Suppl. 48, 344s
Year: 2004

Anti-inflammatory and immunomodulatory potential of Cys LT1 receptor antagonists (LTRA) in steroid dependent persistent asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 136s
Year: 2005

Anti-inflammatory treatment
Source: International Congress 2017 – PG3 Bronchiectasis
Year: 2017


Differences in the glucocorticoid to progesterone receptor selectivity of inhaled glucocorticoids
Source: Eur Respir J 2006; 27: 511-516
Year: 2006



Potential role of antidepressants as part of anticancer therapy
Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients
Year: 2011


Cardioprotective effects of inhaled corticosteroid-containing combination therapy in COPD
Source: Eur Respir J, 53 (2) 1802420; 10.1183/13993003.02420-2018
Year: 2019



In vitro pharmacological profile of SMP-028, a novel potent anti-inflammatory agent
Source: Annual Congress 2010 - Models of airways disease
Year: 2010